| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/20/2006 | CN1833650A Jixuedai dispersion tablet having function of promoting wound reunion, and its prepn. method |
| 09/20/2006 | CN1833649A Jixuedai gel with action of promoting wound reunion, and prepn. thereof |
| 09/20/2006 | CN1833648A Jixuedai drip pill with action of promoting wound reunion, and its prepn. method |
| 09/20/2006 | CN1833647A Clinical preparation of compounded tall gastrodia tuber |
| 09/20/2006 | CN1833646A Active substance of oxidized low density lipoprotein derivative for treating arterial thrombus form |
| 09/20/2006 | CN1833645A Huangyangning dispersion tablets and prepn. process |
| 09/20/2006 | CN1833644A Abrotine, its derivative dihydro-abrotine, artemether, arteether and arte sunate in use of pharmacy |
| 09/20/2006 | CN1833643A Entikawei solid dispersion compsns. and prepn. thereof |
| 09/20/2006 | CN1833642A Torasemide freeze-drying preparation and prepn. method |
| 09/20/2006 | CN1833641A Preparation and technique of ondansetron hydrochloride oral liquor |
| 09/20/2006 | CN1833640A Medicinal componds contg taurine |
| 09/20/2006 | CN1833639A 'Xindakang' dispersion tablets and prepn. method |
| 09/20/2006 | CN1833638A Oral preparation compsns. for expectorant |
| 09/20/2006 | CN1833637A Novel tiopronin freeze drying powder preparation and its prepn. process |
| 09/20/2006 | CN1833636A Application of biphenyl cyclooctadiene lignin in treatment of tumour medicine |
| 09/20/2006 | CN1833635A Static point patch |
| 09/20/2006 | CN1833521A Method of removing caffeine from caffeine-containing catechin compound composition |
| 09/20/2006 | CN1276086C A double-stranded DNA molecule and its use in preparing medicine for inhibiting hepatitis B virus replication |
| 09/20/2006 | CN1276083C Altering gene expression with ssDNA produced in vivo |
| 09/20/2006 | CN1275977C O-aryl glucoside SGL T2 inhibitors |
| 09/20/2006 | CN1275970C Novel carbapenem derivatives |
| 09/20/2006 | CN1275969C Application of active ingredient of coumarin category distilled from dahurian angelica in preparing medicine for curing high blood pressure and its extracting method |
| 09/20/2006 | CN1275968C Non crystalline tricyclic triazolobenzazepine derivative |
| 09/20/2006 | CN1275967C Benzensulfonic acid indol-5-yl esters and antigonists of the 5-HT6 receptor |
| 09/20/2006 | CN1275966C Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for prodn. thereof and pharmaceutical compsns. contg. said derivatives |
| 09/20/2006 | CN1275965C Derivatives of variolin b |
| 09/20/2006 | CN1275964C 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation |
| 09/20/2006 | CN1275962C Novel anticholinergic agents that can be used as medicaments and method for the production thereof |
| 09/20/2006 | CN1275961C Photoactive dicyclic alcohol and its prepn, medicinal composition and use |
| 09/20/2006 | CN1275959C Pterocarya stenoptera extract, its preparation and use |
| 09/20/2006 | CN1275958C Genistein-3'-sodium sulfonate, dimethylation daidzein-3'-sodium sulfonate, their preparing process and pharmaceutical use |
| 09/20/2006 | CN1275954C Hydroxamic acid derivatives |
| 09/20/2006 | CN1275953C Retinol derivatives and cosmestics composition containing the same |
| 09/20/2006 | CN1275951C Novel benzothiazine derivatives, their preparation and use |
| 09/20/2006 | CN1275947C Nitrogen-contg. heterocyclic carboxamide derivatives or salt thereof |
| 09/20/2006 | CN1275945C Meptazinol ortho-propionyloxy-cis-benzyl acrylate and its salts and their production method |
| 09/20/2006 | CN1275942C Benzyloxy substituted indole compound and its analog and their production method and application |
| 09/20/2006 | CN1275940C New phenylalkyloxy-phenyl derivatives |
| 09/20/2006 | CN1275938C Thyroid hormone receptor atagonists for treating cardiac and metabolic disorders II |
| 09/20/2006 | CN1275936C Crystals of hydroxynorephedrine derivative |
| 09/20/2006 | CN1275923C Use of 2',4'-dihydroxy-6'-methoxy-3',5'-dimethyl chalkone as reversing agent for resistance of multiple tumours drugs |
| 09/20/2006 | CN1275917C Glucocorticoid receptor modulators |
| 09/20/2006 | CN1275916C Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 09/20/2006 | CN1275650C Coupled compound of 5-methyl-morpholine-3-amino-2-oxazolidinone and preparation method thereof |
| 09/20/2006 | CN1275637C Medicine for treating oral disease |
| 09/20/2006 | CN1275635C Compound plaster of dahurian angelica root and its preparation method |
| 09/20/2006 | CN1275621C Extract product of Chinese traditional medicine as well as preparation method and application |
| 09/20/2006 | CN1275620C Medicine for treating senile dementia |
| 09/20/2006 | CN1275616C Compsn. of medication for treating burns and scalds |
| 09/20/2006 | CN1275615C Levulose absorption retardant, compound, food and levulose absorption repressor |
| 09/20/2006 | CN1275609C Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and its preparing process |
| 09/20/2006 | CN1275608C Medicine for treating oral cavity ulcer and method for preparing same |
| 09/20/2006 | CN1275605C Guibiegongjiang capsule and its preparation method |
| 09/20/2006 | CN1275600C Vitamin-medicine composition and its use |
| 09/20/2006 | CN1275599C Cyclophosphadenosine glucosamine infusion prepn., and its prepn. process |
| 09/20/2006 | CN1275598C Medicine for promoting wound healing |
| 09/20/2006 | CN1275597C System with extensible released drug containing extract of hawkthom leaves |
| 09/20/2006 | CN1275596C Application of probuco monoester intreating amgiocardiopathy and inflammatry disease |
| 09/20/2006 | CN1275595C Medicinal composition containing gamma-tributyrobetaine |
| 09/20/2006 | CN1275594C Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 09/20/2006 | CN1275593C Dispersible tablet of tamoxifen citrate and preparation method thereof |
| 09/20/2006 | CN1275591C Traditional Chinese medicine slow-releasing medicine for treating cardiovascular disease and its preparation method |
| 09/20/2006 | CN1275589C Slow releasing injection contg. antiparasitic medicine |
| 09/20/2006 | CN1275543C Composite fungi amylose nutrient |
| 09/19/2006 | USRE39300 Inhibiting the development of tolerance to and/or dependence on an addictive substance |
| 09/19/2006 | USRE39298 Supplemented and unsupplemented tissue sealants, methods of their production and use |
| 09/19/2006 | US7110650 Method for configuring air-core photonic-bandgap fibers free of surface modes |
| 09/19/2006 | US7109380 Oxymethylidene-substituted, e.g., 2-(1-methoxy-ethylidene)-cyclopent-4-ene-1,3-diones; inhibit fluconazole-resistant C. albicans strains; may be used for the treatment of life-threatening candidiasis associated with immunocompromised patients. |
| 09/19/2006 | US7109364 Compounds containing a specific branched chain end terminal group, which is isopropyl, sec.-butyl, or tert.-butyl; a polar leading group, and long chain aliphatic, non-cyclic, saturated or nonsaturated linking groups |
| 09/19/2006 | US7109362 A solution containing a molar excess of sodium sulfide trihydrate and sulfur in methanol, and its reaction with 7,8-bis(hydrocarbylsulfonyloxy)octanoic acid ester to form dihydrolipoic acid (which may be oxidized) and its reaction with a bis(hydrocarbylsulfonyloxy)alkane to form a 1,2-dithiacycloalkane |
| 09/19/2006 | US7109361 Isolation of lutein from alfalfa |
| 09/19/2006 | US7109354 Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 09/19/2006 | US7109351 Fused pyrrolecarboxamides; GABA brain receptor ligands |
| 09/19/2006 | US7109347 Inhibitor is an amino acid linked to a thiazolidine or a pyrrolidine group by a peptide bond, e.g., L-threo-isoleucylpyrrolidine, L-allo-isoleucylthiazolidine, L-allo-isoleucylpyrrolydine, L-glutamoylthiazolidine, L-glutamoylpyrrolidine, L-glutamoythiazolidine, L-glutamoylpyrrolidine and their salts |
| 09/19/2006 | US7109341 Antitumor agents; such as 2-(4-((7-Bromo-2-quinolinyl)oxy)phenoxy)propionmethylamide |
| 09/19/2006 | US7109339 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists |
| 09/19/2006 | US7109338 For use in the prophylaxis and the treatment of Picornavirus and human rotavirus infections. |
| 09/19/2006 | US7109337 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 09/19/2006 | US7109335 5-[4-(3-Methanesulfonyl-benzylamino)-5-trifluoromethyl-pyrimidin-2-ylamino]-1,3-dihydro-indol-2-one; inhibitors of the FAK protein tyrosine kinases, antiproliferative, antitumor |
| 09/19/2006 | US7109333 5-(4-{3-chloro-4-(3-fluorobenzyloxy)-anilino}-6-quinazolinyl)-furan-2-carbaldehyde; selective inhibition of the protein tyrosine kinase activity, minimising side effects |
| 09/19/2006 | US7109332 2,4-dioxo-3-quinazolinylaryl sulfonylureas |
| 09/19/2006 | US7109331 Antiprotozoa agents; 4-pyrrolidine pyrrolo(3,2-d)pyrimidine and 4-pyrrolidine pyrazolo(4,3-d)pyrimidine derivatives |
| 09/19/2006 | US7109330 {(2-hydroxyethyl)[9-(methylethyl)-6-(3-quinolylamino)purin-2-yl]amino}ethan-1-ol; antiproliferatives, treating rheumatoid arthritis, lupus, type I diabetes, multiple sclerosis, cancer, restenosis, host graft disease, and gout |
| 09/19/2006 | US7109329 Side effect reduction; muscular disorders; trauma |
| 09/19/2006 | US7109323 lyophilization of an aqueous mixture comprising a boronic add compound and a compound having at least two hydroxyl groups produces a stable composition that readily releases the boronic acid compound upon dissolution in aqueous media |
| 09/19/2006 | US7109322 Process for the depletion or removal of endotoxins |
| 09/19/2006 | US7109303 Modified cytokines for use in cancer therapy |
| 09/19/2006 | US7109296 Used to identify modulators of the 5-HT3 serotonin receptor complex, and to reconstitute a more realistic physiological 5-HT3 receptor response in recombinant systems |
| 09/19/2006 | US7109291 Compounds capable of modulating the activity and stimulating the production of a catalytic antibody |
| 09/19/2006 | US7109280 stable, water soluble, resistant to degradation and free from the microbial contamination thus having advantage over natural polymers like chitin and chitosan |
| 09/19/2006 | US7109246 Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug |
| 09/19/2006 | US7109245 Vasoconstrictor cannabinoid analogs |
| 09/19/2006 | US7109244 Animal extract; antitumor agents; anticancer agents |
| 09/19/2006 | US7109241 method of treating for mastitis in cold temperature conditions; antimicrobial composition comprising: 0.01 to 5 wt. % heptanoic acid; greater than 60 wt. % of a freezing point depressant component comprising propylene glycol and glycerin |
| 09/19/2006 | US7109239 for oral administration using sustained release dosage forms; baclofen and baclofen analogs |
| 09/19/2006 | US7109238 Bone disorders; wound healing agent for bones; antiarthritic agents; osteoarthritis; Paget's disease |
| 09/19/2006 | US7109237 Emulsion containing ascorbic acid and its uses in the cosmetics and dermatological fields |
| 09/19/2006 | US7109236 Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents |
| 09/19/2006 | US7109235 Microtubule stabilizing compounds |
| 09/19/2006 | US7109234 Benzoxathiepine derivatives and their use as medicines |